Hana Pharm Co Ltd Market Cap ($97.89 Million)
Market Cap & Net Worth: Hana Pharm Co Ltd (293480)
Hana Pharm Co Ltd market cap. Hana Pharm Co Ltd (KO:293480) has a market capitalization of $97.89 Million (₩144.44 Billion) as of November 4, 2026. Listed on the KO stock exchange, this Korea-based company holds position #19080 globally and #918 in its home market, demonstrating a -0.73% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hana Pharm Co Ltd's stock price ₩8150.00 by its total outstanding shares 17722946 (17.72 Million). Also see 293480 cash flow conversion for how efficiently the company converts equity into cash flow.
Hana Pharm Co Ltd Market Cap History (2018–2026)
Hana Pharm Co Ltd market cap history from 2018 to 2026. Data shows change from $214.99 Million to $97.89 Million (-13.37% CAGR). Check 293480 live share price for real-time trading data and today's change.
Hana Pharm Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hana Pharm Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 293480 net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Hana Pharm Co Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.02x
Hana Pharm Co Ltd's market cap is 0.02 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $214.99 Million | $152.83 Billion | $26.17 Billion | 0.00x | 0.01x |
| 2019 | $219.95 Million | $166.35 Billion | $28.30 Billion | 0.00x | 0.01x |
| 2020 | $256.24 Million | $177.31 Billion | $14.89 Billion | 0.00x | 0.02x |
| 2021 | $226.30 Million | $196.41 Billion | $28.01 Billion | 0.00x | 0.01x |
| 2022 | $211.38 Million | $210.84 Billion | $24.31 Billion | 0.00x | 0.01x |
| 2023 | $161.57 Million | $224.46 Billion | $22.33 Billion | 0.00x | 0.01x |
| 2024 | $130.92 Million | $225.34 Billion | $21.25 Billion | 0.00x | 0.01x |
| 2025 | $134.76 Million | $239.50 Billion | $8.78 Billion | 0.00x | 0.02x |
Competitor Companies of 293480 by Market Capitalization
Companies near Hana Pharm Co Ltd in the global market cap rankings as of November 4, 2026. Also see total assets of Hana Pharm Co Ltd for a full breakdown of the balance sheet.
Key companies related to Hana Pharm Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Hana Pharm Co Ltd (2018–2026)
Market capitalization of Hana Pharm Co Ltd from 2018 to today. Between 2018 and today, Hana Pharm Co Ltd's market cap moved from $214.99 Million to $ 97.89 Million, with a yearly change of -13.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩97.89 Million | -27.36% |
| 2025 | ₩134.76 Million | +2.94% |
| 2024 | ₩130.92 Million | -18.97% |
| 2023 | ₩161.57 Million | -23.56% |
| 2022 | ₩211.38 Million | -6.59% |
| 2021 | ₩226.30 Million | -11.69% |
| 2020 | ₩256.24 Million | +16.50% |
| 2019 | ₩219.95 Million | +2.30% |
| 2018 | ₩214.99 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Hana Pharm Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $97.89 Million USD |
| MoneyControl | $97.89 Million USD |
| MarketWatch | $97.89 Million USD |
| marketcap.company | $97.89 Million USD |
| Reuters | $97.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hana Pharm Co Ltd
Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and an… Read more